Breast Cancer Clinical Landscape and Recent Trends Whitepaper

10 Jan 2020

Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

US FDA Approval Of Lynparza For Pancreatic Cancer Opens Door For PFS Endpoint In Disease

08 Jan 2020

AstraZeneca's PARP inhibitor Lynparza becomes first US FDA-approved drug for pancreatic cancer based on progression-free survival endpoint, providing regulatory precedent for other sponsors to use that development approach; all other pancreatic cancer drugs had been approved based on an overall survival benefit.

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Seven Talking Points At ASH 2019

By Andrew McConaghie 16 Dec 2019

The tireless pace of change in hemato-oncology was showcased in Orlando.

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

How Sustainable Is England's Cancer Drugs Fund?

By Francesca Bruce 20 Nov 2019

The Cancer Drugs Fund has improved access to oncology drugs, but if it is to remain fit for purpose it will need to evolve.

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Accord Strikes Thiotepa Deal With Adienne

By Aidan Fry 20 Nov 2019

Accord Healthcare has secured commercial rights to Adienne’s novel lyophilized formulation of thiotepa in Europe, extending its portfolio of cancer treatments.

Medtech Insight: 世界の医療機器・医療技術の最新情報

Laboratory For Advanced Medicine Appoints New CEO, Prepares To Scale Liquid Biopsy Pipeline

08 Nov 2019

With a new CEO at its helm, Laboratory for Advanced Medicine is preparing to take on the cancer-diagnostics market. Former AncestryDNA executive Kenneth Chahine has joined the company as it plans to drive global commercialization of its artificial intelligence liquid biopsy pipeline.

awareness, Datamonitor Healthcare: 医療用医薬品の市場調...

Post-ESMO Podcast 2019

31 Oct 2019

Listen to this podcast to keep up with the latest translational science and advancements in oncology to come out of the European Society of Medical Oncology (ESMO) Congress 2019. Datmonitor Healthcare’s post-event podcast delivers every important development.

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor...

2019 Post-ESMO Conference Report Extract

31 Oct 2019

Tap into insights and highlights from ESMO’s annual meeting of oncology clinicians, researchers, patient advocates, journalists, and members of the pharmaceutical industry.